Calando Pharmaceuticals

About:

Calando Pharmaceuticals focuses on creating targeted therapeutics for the development of nanoparticle drug formulations.

Website: http://www.insertt.com

Top Investors: Arrowhead Pharmaceuticals

Description:

Calando Pharmaceuticals is a biopharmaceutical company focused on creating targeted therapeutics using its patented and proprietary cyclodextrin-based polymer technologies for the development of nanoparticle drug formulations. Calando’s initial emphasis has been to bring targeted siRNA and small molecule therapeutics to the clinic for oncology applications; however, the technologies are not limited to these classes of molecules and are applicable to a very broad range of therapeutic entities and diseases.

Total Funding Amount:

$11M

Headquarters Location:

Pasadena, California, United States

Founded Date:

2000-01-01

Founders:

Mark E. Davis, Robert Grubbs

Number of Employees:

1-10

Last Funding Date:

2011-01-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai